E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/8/2016 in the Prospect News Emerging Markets Daily.

New Issue: China’s Yestar prices $200 million 6.9% five-year notes at par

New York, Sept. 8 – Yestar International Holdings Co. Ltd. priced a $200 million offering of 6.9% senior notes due 2021 (Ba3/-/BB-) at par, according to a company announcement.

The bookrunners were BofA Merrill Lynch, Credit Suisse (Hong Kong) Ltd., Deutsche Bank AG, Singapore Branch and Haitong International Securities Co. Ltd. BofA was global coordinator.

Proceeds will be used to refinance existing debt, fund capital expenditures and acquisitions, and for general corporate purposes.

Yestar is a Shanghai-based supplier of medical consumables for the in vitro diagnostic market and a manufacturer and distributor of medical imaging products.

Issuer:Yestar International Holdings Co. Ltd.
Issue:Senior notes
Amount:$200 million
Maturity:2021
Coupon:6.9%
Price:Par
Yield:6.9%
Call:Make-whole call until Sept. 15, 2019, then at 103.45, from Sept. 15, 2020 at 101.725
Equity clawback:For 35% at 106.9 until Sept. 15, 2019
Ratings:Moody’s: Ba3
Fitch: BB- (expected)
Pricing date:Sept. 8
Bookrunners:BofA Merrill Lynch (global coordinator), Credit Suisse (Hong Kong) Ltd., Deutsche Bank AG, Singapore Branch and Haitong International Securities Co. Ltd.
Distribution:Regulation S

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.